| Financial Year |
March 31 2023 |
| Monetary Funds |
508,483,916.79 |
| Held-for-trading Financial Assets |
3,500,000.00 |
| Notes Receivable |
29,977,934.93 |
| Accounts Receivable |
797,896,208.76 |
| Advances to Suppliers |
144,929,437.23 |
| Other Receivables |
81,299,243.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,413,754,177.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,972,247.82 |
| Total Current Assets |
3,046,812,162.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,834,510.13 |
| Long-term Equity Investment |
3,000,000.00 |
| Investment Properties |
8,749,168.17 |
| Fixed Assetes |
890,496,557.52 |
| Under-construction Projects |
58,029,461.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
87,360,271.68 |
| R&D expenses |
-- |
| Goodwill |
291,615,059.58 |
| Long-Term Deferred and Prepaid Expenses |
34,504,601.76 |
| Deferred Income Tax Assets |
52,063,995.42 |
| Other Non-Current Assets |
6,909,566.74 |
| Sub-Total of Non-Current Assets |
1,562,800,036.15 |
| Total Assets |
4,609,612,198.32 |
| Short-Term Loans |
969,632,350.24 |
| Trading Financial liabilities |
2,009,063.36 |
| Notes Payable |
135,116,978.24 |
| Accounts Payable |
398,304,550.43 |
| Accounts Received In Advance |
2,860.00 |
| Employee Compensation Payable |
98,050,231.45 |
| Taxes Payable |
41,842,203.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
130,090,681.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
83,722,259.49 |
| Other Current Liabilities |
9,301,833.73 |
| Sub-Total of Current Liabilities |
1,983,323,679.47 |
| Long-term Loans |
729,183,050.05 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
47,908,899.75 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,059,999.97 |
| Other Non-Current Liabilities |
2,281,876.90 |
| Sub-Total of Non-Current Liabilities |
954,189,189.96 |
| Total Liabilities |
2,937,512,869.43 |
| Paid-In Capital(Or Share Stock) |
170,672,000.00 |
| Capital Surplus |
515,384,307.37 |
| Surplus Reserve |
44,506,512.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
944,464,957.12 |
| Minority Stockholder's Interest |
12,214,189.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,659,885,139.06 |
| Owner's Equity（Stockholder's Equity） |
1,672,099,328.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,609,612,198.32 |
